Menta Capital’s Chemed CHE Stock Holding History

Menta Capital’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-778	Closed	-$220K	–	507
2018 Q4	$220K	Buy	+778	New	+$235K	0.08%	396
2015 Q2	–	Sell	-2,100	Closed	-$251K	–	673
2015 Q1	$251K	Buy	+2,100	New	+$233K	0.03%	592

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Menta Capital's CHE Position: Q1 2019 in Review

Menta Capital sold out of Chemed (CHE) in Q1 2019, closing a stake of 778 shares — an estimated $220K sold.

Menta Capital first reported a position in CHE in Q1 2015 and held it in 2 quarters. The position peaked at $251K in Q1 2015. 382 funds tracked by Wall St. Rank hold CHE as of Q1 2019.

Menta Capital reported no remaining Chemed position as of Q1 2019 after selling out during the quarter.
Menta Capital sold 778 Chemed shares in Q1 2019, an estimated $220K.
Menta Capital first reported a position in Chemed in Q1 2015 and held it in 2 quarters.
Menta Capital's Chemed position peaked at $251K in Q1 2015.
382 funds tracked by Wall St. Rank held Chemed as of Q1 2019.

Based on Menta Capital's 13F filing for Q1 2019, filed 1 May 2019.